This Article Full Text (PDF) All Versions of this Article: 1740774509344777v1 6/5/403    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Comté, L. Articles by Vrijens, B. PubMed PubMed Citation Articles by Comté, L. Articles by Vrijens, B. Social Bookmarking                         What's this?

Linear and loglinear structural mean models to evaluate the benefits of an on-demand dosing regimen

Department of Mathematics, University of Liège, Grande Traverse 12, B37, Liège 4000, Belgium

Stijn Vansteelandt

Department of Applied Mathematics and Computer Science, Ghent University, Ghent, Belgium

Eric Tousset

Pharmionic Research Center, Visé, Belgium

Garth Baxter

Wyeth Pharmaceuticals, Berkshire, UK

Bernard Vrijens

Pharmionic Research Center, Visé, Belgium, bernard.vrijens{at}pharmionic.eu

Background Structural mean models can be used to estimate treatment efficacy when drug exposure varies. We applied stuctural mean model to evaluate the clinical benefits of a proton pump inhibitor prescribed to be taken as needed to alleviate epigastric pain. We also investigated a new diagnostic approach to evaluate model assumptions.

Methods All patients were suffering from nonerosive reflux disease or functional ulcer-like dyspepsia and were prescribed a proton pump inhibitor to be taken as needed for relief of epigastric pain. The primary endpoint was a score variable that expresses the magnitude of gastro-intestinal symptoms at 8 weeks after randomization. We developed linear and loglinear versions of the structural mean models to derive an unbiased estimator of the reduction in symptom score as a function of exposure to the test drug. Semi-parametric models based on splines and corresponding simultaneous confidence bands identified the presence of potential interactions between drug exposure and baseline covariates.

Results The on-demand dosing regimen generated a wide range of drug exposure. Application of SMM showed that the potential treatment-induced reduction in symptom score was much greater than the average treatment reduction observed in this population of patients. Our diagnostic tool was useful for detecting the interaction between drug exposure and baseline covariates. Limitations Analysis could only be performed over the first 2 months after randomization because, afterwards, many patients dropped out from the placebo group. Conclusions The structural mean model approach allows one to estimate treatment efficacy in the presence of variable drug exposure. Similar results were obtained using linear and loglinear structural mean model. Clinical Trials 2009; 6: 403—415. http://ctj.sagepub.com

This version was published on October 1, 2009

Clinical Trials, Vol. 6, No. 5, 403-415 (2009)
DOI: 10.1177/1740774509344777


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?